|
Irinotecan Viatris 20 mg/ ml con inf 5x2 ml/40 mg (liek.inj.skl.hnedá)
20 mg/1 ml
|
Koncentrát na infúzny roztok (Infúzny koncentrát - platné do okt2020) |
L01CE02
|
Viatris Limited |
—
|
|
Irinotecan Viatris 20 mg/ ml con inf 5x25 ml/500 mg (liek.inj.skl.hnedá)
20 mg/1 ml
|
Koncentrát na infúzny roztok (Infúzny koncentrát - platné do okt2020) |
L01CE02
|
Viatris Limited |
—
|
|
Irinotecan Viatris 20 mg/ ml con inf 5x5 ml/100 mg (liek.inj.skl.hnedá)
20 mg/1 ml
|
Koncentrát na infúzny roztok (Infúzny koncentrát - platné do okt2020) |
L01CE02
|
Viatris Limited |
—
|
|
Klertis 12,5 mg cps dur 28x12,5 mg (blis.PVC/Aclar/Al)
12,5 mg
|
Tvrdá kapsula |
L01EX01
|
Egis Pharmaceuticals PLC |
—
|
|
Klertis 12,5 mg cps dur 30x12,5 mg (fľ.HDPE)
12,5 mg
|
Tvrdá kapsula |
L01EX01
|
Egis Pharmaceuticals PLC |
—
|
|
Klertis 25 mg cps dur 28x25 mg (blis.PVC/Aclar/Al)
25 mg
|
Tvrdá kapsula |
L01EX01
|
Egis Pharmaceuticals PLC |
—
|
|
Klertis 25 mg cps dur 30x25 mg (fľ.HDPE)
25 mg
|
Tvrdá kapsula |
L01EX01
|
Egis Pharmaceuticals PLC |
—
|
|
Klertis 50 mg cps dur 28x50 mg (blis.PVC/Aclar/Al)
50 mg
|
Tvrdá kapsula |
L01EX01
|
Egis Pharmaceuticals PLC |
—
|
|
Klertis 50 mg cps dur 30x50 mg (fľ.HDPE)
50 mg
|
Tvrdá kapsula |
L01EX01
|
Egis Pharmaceuticals PLC |
—
|
|
Krufton 150 mg tvrdé kapsuly cps dur 112 (4x28)x150 mg (blis.OPA/Al/PVC//Al)
150 mg
|
Tvrdá kapsula |
L01EA03
|
Egis Pharmaceuticals PLC |
—
|
|
Krufton 150 mg tvrdé kapsuly cps dur 112 (4x28)x150 mg (blis.PVC/PE/PVDC//Al)
150 mg
|
Tvrdá kapsula |
L01EA03
|
Egis Pharmaceuticals PLC |
—
|
|
Krufton 200 mg tvrdé kapsuly cps dur 112 (4x28)x200 mg (blis.OPA/Al/PVC//Al)
200 mg
|
Tvrdá kapsula |
L01EA03
|
Egis Pharmaceuticals PLC |
—
|
|
Krufton 200 mg tvrdé kapsuly cps dur 112 (4x28)x200 mg (blis.PVC/PE/PVDC//Al)
200 mg
|
Tvrdá kapsula |
L01EA03
|
Egis Pharmaceuticals PLC |
—
|
|
Krufton 50 mg tvrdé kapsuly cps dur 120 (3x40)x50 mg (blis.OPA/Al/PVC//Al)
50 mg
|
Tvrdá kapsula |
L01EA03
|
Egis Pharmaceuticals PLC |
—
|
|
Krufton 50 mg tvrdé kapsuly cps dur 120 (3x40)x50 mg (blis.PVC/PE/PVDC//Al)
50 mg
|
Tvrdá kapsula |
L01EA03
|
Egis Pharmaceuticals PLC |
—
|
|
Lanvis tbl 25x40 mg (liek.skl.)
40 mg
|
Tableta |
L01BB03
|
Aspen Pharma Trading Limited |
—
|
|
Lapatinib Stada 250 mg filmom obalené tablety tbl flm 140 (2x70) x250 mg (blis.Al/OPA/Al/PVC-multibal.)
250 mg
|
Filmom obalená tableta |
L01EH01
|
STADA Arzneimittel AG |
—
|
|
Lapatinib Stada 250 mg filmom obalené tablety tbl flm 140x1 (2x70x1) x250 mg (blis.Al/OPA/Al/PVC-jednotk.bal.-multibal.)
250 mg
|
Filmom obalená tableta |
L01EH01
|
STADA Arzneimittel AG |
—
|
|
Lapatinib Stada 250 mg filmom obalené tablety tbl flm 70x1x250 mg (blis.Al/OPA/Al/PVC-jednotk.bal.)
250 mg
|
Filmom obalená tableta |
L01EH01
|
STADA Arzneimittel AG |
—
|
|
Lapatinib Stada 250 mg filmom obalené tablety tbl flm 70x250 mg (blis.Al/OPA/Al/PVC)
250 mg
|
Filmom obalená tableta |
L01EH01
|
STADA Arzneimittel AG |
—
|
|
Lapatinib Stada 250 mg filmom obalené tablety tbl flm 84x1x250 mg (blis.Al/OPA/Al/PVC-jednotk.bal.)
250 mg
|
Filmom obalená tableta |
L01EH01
|
STADA Arzneimittel AG |
—
|
|
Lapatinib Stada 250 mg filmom obalené tablety tbl flm 84x250 mg (blis.Al/OPA/Al/PVC)
250 mg
|
Filmom obalená tableta |
L01EH01
|
STADA Arzneimittel AG |
—
|
|
Lapatinib Stada 250 mg filmom obalené tablety tbl flm 84x250 mg (fľ.HDPE)
250 mg
|
Filmom obalená tableta |
L01EH01
|
STADA Arzneimittel AG |
—
|
|
Lentulil 10 mg cps dur 30x10 mg (blis.OPA/Al/PVC/Al)
10 mg
|
Tvrdá kapsula |
L01EX08
|
Egis Pharmaceuticals PLC |
—
|